Innovative Surgical Products neoSurgical has developed neoClose, a new standard for laparoscopic port site closure, positioning the company as a potential leader in surgical device innovation with a sizeable $300 million market opportunity.

Growing Market Focus With approval for sale in both the US and Europe, neoSurgical is expanding its geographical reach, creating sales opportunities across major markets in health systems seeking advanced minimally invasive surgical products.

Early Revenue Stage Currently generating up to $1 million in revenue, neoSurgical offers an early-stage partnership environment, ideal for clinical trials, product adoption, and strategic alliances to accelerate market penetration.

Tech-Driven Approach The company’s use of modern web technologies indicates an emphasis on digital presence and data analytics, which can be leveraged to target hospitals and surgical centers that prioritize innovative, tech-enabled solutions.

Strategic Partner Opportunities Operating in a space with competitors of varying sizes, neoSurgical can position itself for collaborations with established medical device companies or health systems seeking innovative minimally invasive surgical tools.